214 related articles for article (PubMed ID: 26938303)
1. LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway.
Wang X; Zhang W; Tang J; Huang R; Li J; Xu D; Xie Y; Jiang R; Deng L; Zhang X; Chai Y; Qin X; Sun B
Cell Death Dis; 2016 Mar; 7(3):e2130. PubMed ID: 26938303
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA LINC01225 promotes proliferation, invasion and migration of gastric cancer via Wnt/β-catenin signalling pathway.
Xu Y; Zhang G; Zou C; Qi W; Gong Z; Zhang G; Ma G; Zhang W; Jiang P
J Cell Mol Med; 2019 Nov; 23(11):7581-7591. PubMed ID: 31460694
[TBL] [Abstract][Full Text] [Related]
3. A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma.
Tang J; Zhuo H; Zhang X; Jiang R; Ji J; Deng L; Qian X; Zhang F; Sun B
Cell Death Dis; 2014 Dec; 5(12):e1549. PubMed ID: 25476897
[TBL] [Abstract][Full Text] [Related]
4. Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.
Zheng ZK; Pang C; Yang Y; Duan Q; Zhang J; Liu WC
J Int Med Res; 2018 Jan; 46(1):348-356. PubMed ID: 28856933
[TBL] [Abstract][Full Text] [Related]
5. Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma.
Yao Z; Jia C; Tai Y; Liang H; Zhong Z; Xiong Z; Deng M; Zhang Q
Aging (Albany NY); 2020 Jun; 12(12):11843-11863. PubMed ID: 32554864
[TBL] [Abstract][Full Text] [Related]
6. The long noncoding RNA, EGFR-AS1, a target of GHR, increases the expression of EGFR in hepatocellular carcinoma.
Qi HL; Li CS; Qian CW; Xiao YS; Yuan YF; Liu QY; Liu ZS
Tumour Biol; 2016 Jan; 37(1):1079-89. PubMed ID: 26271667
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
Peng W; Fan H
Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA CCHE1 indicates a poor prognosis of hepatocellular carcinoma and promotes carcinogenesis via activation of the ERK/MAPK pathway.
Peng W; Fan H
Biomed Pharmacother; 2016 Oct; 83():450-455. PubMed ID: 27427851
[TBL] [Abstract][Full Text] [Related]
10. A Noninvasive Prediction Nomogram for Lymph Node Metastasis of Hepatocellular Carcinoma Based on Serum Long Noncoding RNAs.
Ma J; Zhang L; Bian HR; Lu ZG; Zhu L; Yang P; Zeng ZC; Xiang ZL
Biomed Res Int; 2019; 2019():1710670. PubMed ID: 31355249
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
Qiu L; Tang Q; Li G; Chen K
Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
[TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding RNAs: Potential Biomarkers and Targets for Hepatocellular Carcinoma Therapy and Diagnosis.
Yuan D; Chen Y; Li X; Li J; Zhao Y; Shen J; Du F; Kaboli PJ; Li M; Wu X; Ji H; Cho CH; Wen Q; Li W; Xiao Z; Chen B
Int J Biol Sci; 2021; 17(1):220-235. PubMed ID: 33390845
[TBL] [Abstract][Full Text] [Related]
14. Loss of protocadherin-17 (PCDH-17) promotes metastasis and invasion through hyperactivation of EGFR/MEK/ERK signaling pathway in hepatocellular carcinoma.
Dang Z; Shangguan J; Zhang C; Hu P; Ren Y; Lv Z; Xiang H; Wang X
Tumour Biol; 2016 Feb; 37(2):2527-35. PubMed ID: 26386721
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling.
Zhang JY; Weng MZ; Song FB; Xu YG; Liu Q; Wu JY; Qin J; Jin T; Xu JM
Int J Oncol; 2016 Apr; 48(4):1590-8. PubMed ID: 26892468
[TBL] [Abstract][Full Text] [Related]
17. Lower serum soluble-EGFR is a potential biomarker for metastasis of HCC demonstrated by N-glycoproteomic analysis.
Hu H; Gao L; Wang C; Li Y; Ma H; Chen L; Qin J; Liu B; Liu Y; Liang C
Discov Med; 2015 May; 19(106):333-41. PubMed ID: 26105696
[TBL] [Abstract][Full Text] [Related]
18. Visfatin increases miR-21 to promote migration in HCC.
Liang N; Chen Y; Yang L; He S; Liu T
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):48-52. PubMed ID: 29808800
[TBL] [Abstract][Full Text] [Related]
19. Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma.
Xie H; Ma H; Zhou D
Biomed Res Int; 2013; 2013():136106. PubMed ID: 23762823
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of long non-coding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin.
Chang L; Li C; Lan T; Wu L; Yuan Y; Liu Q; Liu Z
Mol Med Rep; 2016 Feb; 13(2):1541-50. PubMed ID: 26707238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
